Randomized clinical trial of low dose suramin intravenous infusions for treatment of autism spectrum disorder

BACKGROUND: There is a critical need for effective treatment of the core symptoms of autism spectrum disorder (ASD). The purinergic antagonist suramin may improve core symptoms through restoration of normal mitochondrial function and reduction of neuro-inflammation via its known antagonism of P2X an...

Descripción completa

Detalles Bibliográficos
Autores principales: Hough, David, Mao, Alice R., Aman, Michael, Lozano, Reymundo, Smith-Hicks, Constance, Martinez-Cerdeno, Veronica, Derby, Michael, Rome, Zachary, Malan, Niel, Findling, Robert L.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2023
Materias:
Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10626700/
https://www.ncbi.nlm.nih.gov/pubmed/37932739
http://dx.doi.org/10.1186/s12991-023-00477-8

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10626700/
https://www.ncbi.nlm.nih.gov/pubmed/37932739
http://dx.doi.org/10.1186/s12991-023-00477-8

Ejemplares similares